A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Clinical trial NCT06175494 · UNKNOWN
Trial details
- NCT number
- NCT06175494
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-07-31
- Enrollment
- 4800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.